SD Biosensor’s Triplex Test: A Rapid Diagnostic Tool for COVID-19, Flu A & B
As respiratory illnesses continue to circulate globally, accurate and rapid diagnostics are crucial for effective public health management and individual care. SD Biosensor, a South Korean company specializing in in-vitro diagnostics, offers a combined test capable of detecting COVID-19, influenza A, and influenza B simultaneously. This diagnostic tool, known as the STANDARD Q COVID-19 Ag Home Test combined with influenza A/B detection, provides a convenient and relatively quick method for identifying the causative agent of respiratory symptoms. The availability of such multiplex tests is becoming increasingly important as healthcare systems navigate the complexities of overlapping respiratory virus seasons.
The SD Biosensor triplex test is designed for self-testing, allowing individuals experiencing respiratory symptoms to quickly assess their condition. The test utilizes a nasal swab sample and employs immunochromatography to detect the presence of specific antigens associated with each virus. Results are available within 15 minutes, offering a significant advantage over laboratory-based PCR tests, which typically require longer turnaround times. This speed is particularly valuable in the early stages of illness when timely intervention can be most effective. The test has received official approval from the South Korean Ministry of Food and Drug Safety (MFDS), demonstrating its adherence to regulatory standards.
How the Triplex Test Works: A Closer Appear at the Technology
The STANDARD Q COVID-19 Ag Home Test, when combined with influenza A/B detection, relies on the principle of immunochromatography. This technique involves the use of antibodies that specifically bind to viral antigens. A nasal swab is used to collect a sample from the patient. This sample is then mixed with a reagent solution and applied to a test strip. If the target virus (COVID-19, influenza A, or influenza B) is present in the sample, the corresponding antibodies will bind to the viral antigens, forming a complex that is visible as a colored line on the test strip. The presence or absence of these lines indicates a positive or negative result for each virus. According to SD Biosensor, the test boasts a sensitivity of 94.94% and a specificity of 100% for COVID-19 antigen detection, though it’s important to note that sensitivity and specificity can vary depending on the study and population tested.
The test’s portability and ease of use make it suitable for a variety of settings, including homes, schools, workplaces, and healthcare facilities. The kit requires no specialized equipment, further simplifying the testing process. SD Biosensor offers the test in various pack sizes, ranging from single kits to packs of 25, catering to different testing needs. The recommended storage temperature for the test is between 2-30°C (36-86°F), making it relatively easy to store and transport. The company highlights that the test’s performance has been validated through evaluations conducted in Germany, specifically in Berlin.
Understanding the Limitations and Importance of Confirmatory Testing
While rapid antigen tests like the SD Biosensor triplex test offer a convenient and timely diagnostic solution, it’s crucial to understand their limitations. Antigen tests are generally less sensitive than PCR tests, meaning they may be more likely to produce false negative results, particularly in individuals with low viral loads or those who are asymptomatic. As noted in product information, self-tests should be used as a supplementary tool and should not replace a PCR test, especially for individuals with respiratory symptoms or suspected infection. The company explicitly advises that individuals experiencing respiratory symptoms or suspected infection should prioritize a PCR test whenever possible.
The use of self-tests is particularly relevant when rapid PCR testing is unavailable. Though, We see vital to remember that a negative result from a self-test does not definitively rule out infection. Individuals with negative results who continue to experience symptoms should consult with a healthcare professional for further evaluation and potential PCR testing. The SD Biosensor test is intended to aid in the diagnosis of respiratory infections but should not be used as the sole basis for clinical decision-making.
The Broader Context: Multiplex Testing and Respiratory Virus Surveillance
The development and deployment of multiplex tests like the SD Biosensor triplex test represent a significant advancement in respiratory virus diagnostics. The ability to simultaneously detect multiple pathogens streamlines the diagnostic process and provides healthcare providers with more comprehensive information for patient management. Here’s particularly important during periods of co-circulation of multiple respiratory viruses, such as COVID-19 and influenza, where distinguishing between infections can be challenging based on symptoms alone.
Multiplex testing also plays a crucial role in public health surveillance efforts. By tracking the prevalence of different respiratory viruses, public health officials can monitor trends, identify outbreaks, and implement targeted interventions to mitigate the spread of infection. The availability of rapid and accurate diagnostic tests is essential for effective surveillance and response. SD Biosensor positions itself as a leading global provider of in-vitro diagnostic reagents, contributing to improved quality of life through accurate and rapid disease diagnosis.
Availability and Cost
The SD Biosensor COVID-19/Flu A/B 3-in-1 test is available for purchase through various retailers. Pricing varies depending on the pack size and retailer. As of early March 2026, a 25-test kit is available for approximately 99,000 Korean Won (roughly $75 USD), whereas prices may fluctuate. The test is also available in smaller pack sizes, such as single kits and 5-test packs, at correspondingly lower prices. Consumers can identify the test through online retailers like Danawa and SSG.com, as well as through medical supply companies.
Key Takeaways
- The SD Biosensor triplex test offers a rapid and convenient method for detecting COVID-19, influenza A, and influenza B simultaneously.
- The test utilizes immunochromatography and provides results within 15 minutes.
- While offering a valuable diagnostic tool, the test has limitations and should not replace PCR testing, especially for symptomatic individuals.
- Multiplex testing plays a crucial role in both clinical diagnosis and public health surveillance.
- The test is readily available in various pack sizes and through multiple retailers.
The ongoing evolution of respiratory viruses necessitates continuous innovation in diagnostic technologies. The SD Biosensor triplex test represents a step forward in providing accessible and timely diagnostic information, empowering individuals and healthcare professionals to make informed decisions. Further developments in rapid diagnostic testing will undoubtedly play a critical role in managing future respiratory virus outbreaks and protecting public health. The next key development to watch will be the potential for even more comprehensive multiplex tests that can detect a wider range of respiratory pathogens.
What are your experiences with at-home rapid tests? Share your thoughts in the comments below, and please share this article with anyone who might find it helpful.
Keep reading